Briefing
PEGASUS: liquid-biopsy-guided adjuvant therapy for stage III and high-risk stage II colon cancer
Phase 2 study that changes capecitabine, CAPOX, or FOLFIRI according to serial ctDNA after surgery for microsatellite-stable stage III or T4N0 stage II colon cancer. ClinicalTrials.gov lists the status as unknown.
- Design: Phase 2 · Unknown